nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphemanil Methylsulfate—Diphenylpyraline—SLC6A3—Parkinson's disease	0.0256	0.617	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—CYP2E1—Parkinson's disease	0.00704	0.17	CrCbGaD
Diphemanil Methylsulfate—Tamoxifen—CYP2D6—Parkinson's disease	0.00517	0.125	CrCbGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00397	0.00414	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00396	0.00413	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Regulation of insulin secretion—INS—Parkinson's disease	0.00392	0.00409	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—DRD1—Parkinson's disease	0.00375	0.00391	CbGpPWpGaD
Diphemanil Methylsulfate—Tamoxifen—ABCB1—Parkinson's disease	0.00369	0.0889	CrCbGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00366	0.00382	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00365	0.00381	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—DRD3—Parkinson's disease	0.00363	0.00379	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00362	0.00378	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00361	0.00377	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00359	0.00375	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00358	0.00374	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—GRM4—Parkinson's disease	0.00349	0.00364	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—GRM4—Parkinson's disease	0.00348	0.00363	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—TH—Parkinson's disease	0.00334	0.00349	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—PENK—Parkinson's disease	0.00331	0.00345	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—PENK—Parkinson's disease	0.0033	0.00344	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—DRD2—Parkinson's disease	0.00328	0.00343	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—HTR7—Parkinson's disease	0.00328	0.00343	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00321	0.00335	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.0032	0.00334	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00318	0.00332	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00317	0.00331	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00314	0.00327	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00313	0.00326	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Integration of energy metabolism—INS—Parkinson's disease	0.00308	0.00322	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00307	0.0032	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00306	0.00319	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—PDYN—Parkinson's disease	0.00302	0.00315	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—PDYN—Parkinson's disease	0.00301	0.00314	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00297	0.0031	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00296	0.00309	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DGKQ—Parkinson's disease	0.0029	0.00303	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00289	0.00302	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—GRM5—Parkinson's disease	0.00281	0.00293	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—GRM5—Parkinson's disease	0.0028	0.00292	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00279	0.00291	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00278	0.0029	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00272	0.00284	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.00271	0.00283	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00269	0.00281	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00269	0.00281	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00268	0.0028	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00268	0.0028	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00268	0.0028	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00267	0.00279	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.00263	0.00275	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.00263	0.00275	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00263	0.00274	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DGKQ—Parkinson's disease	0.00262	0.00274	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GPR37—Parkinson's disease	0.00262	0.00274	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00262	0.00274	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00255	0.00266	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00254	0.00265	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00249	0.0026	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00248	0.00259	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00244	0.00254	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00243	0.00253	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00241	0.00251	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.0024	0.0025	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00239	0.00249	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00238	0.00249	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.0023	0.0024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.0023	0.0024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.0023	0.0024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.0023	0.0024	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.0022	0.00229	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—GRK5—Parkinson's disease	0.00219	0.00229	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00218	0.00227	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00217	0.00227	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ND3—Parkinson's disease	0.00208	0.00217	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MCCC1—Parkinson's disease	0.00208	0.00217	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00207	0.00216	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—HTR1A—Parkinson's disease	0.00207	0.00216	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.00204	0.00213	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—TAC1—Parkinson's disease	0.00204	0.00212	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.002	0.00209	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—DRD1—Parkinson's disease	0.002	0.00208	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.002	0.00208	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GRK5—Parkinson's disease	0.00199	0.00208	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.00197	0.00206	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—GRM4—Parkinson's disease	0.00196	0.00205	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—TALDO1—Parkinson's disease	0.00196	0.00204	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—OMD—Parkinson's disease	0.00196	0.00204	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.00194	0.00202	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—DRD3—Parkinson's disease	0.00193	0.00202	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00188	0.00196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00188	0.00196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—VPS35—Parkinson's disease	0.00188	0.00196	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—VPS35—Parkinson's disease	0.00187	0.00195	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.00187	0.00195	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PENK—Parkinson's disease	0.00186	0.00194	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NDUFB11—Parkinson's disease	0.00185	0.00193	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00184	0.00192	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00184	0.00192	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.00179	0.00187	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GRM4—Parkinson's disease	0.00178	0.00186	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GCH1—Parkinson's disease	0.00177	0.00185	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.00175	0.00183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.00175	0.00183	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—DRD2—Parkinson's disease	0.00175	0.00182	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—HTR7—Parkinson's disease	0.00175	0.00182	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.00171	0.00178	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—PDYN—Parkinson's disease	0.0017	0.00178	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PENK—Parkinson's disease	0.0017	0.00177	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PENK—Parkinson's disease	0.00169	0.00176	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00161	0.00168	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00161	0.00168	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.00159	0.00166	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—GRM5—Parkinson's disease	0.00158	0.00165	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—FBP1—Parkinson's disease	0.00158	0.00164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—DBH—Parkinson's disease	0.00158	0.00164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GBA—Parkinson's disease	0.00158	0.00164	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.00156	0.00162	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GPR37—Parkinson's disease	0.00156	0.00162	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.00155	0.00162	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DGKQ—Parkinson's disease	0.00155	0.00162	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GPR37—Parkinson's disease	0.00155	0.00162	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—PDYN—Parkinson's disease	0.00155	0.00161	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—GRM5—Parkinson's disease	0.00144	0.00151	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—GRM5—Parkinson's disease	0.00144	0.0015	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00142	0.00148	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00142	0.00148	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—EDN1—Parkinson's disease	0.0014	0.00147	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—EDN1—Parkinson's disease	0.0014	0.00146	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00135	0.00141	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00135	0.0014	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—MAPK8—Parkinson's disease	0.00125	0.0013	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—RIT2—Parkinson's disease	0.00124	0.0013	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—RIT2—Parkinson's disease	0.00124	0.00129	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR ligand binding—HTR2A—Parkinson's disease	0.00123	0.00128	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00123	0.00128	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR ligand binding—HTR2A—Parkinson's disease	0.00122	0.00128	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00122	0.00128	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GRK5—Parkinson's disease	0.00118	0.00123	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GRK5—Parkinson's disease	0.00118	0.00123	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00117	0.00122	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00117	0.00122	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—DDC—Parkinson's disease	0.00116	0.00121	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—TAC1—Parkinson's disease	0.00115	0.0012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—TAC1—Parkinson's disease	0.00115	0.0012	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DRD1—Parkinson's disease	0.00113	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DRD1—Parkinson's disease	0.00113	0.00118	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DRD3—Parkinson's disease	0.0011	0.00114	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DRD3—Parkinson's disease	0.00109	0.00114	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GSTA4—Parkinson's disease	0.00109	0.00114	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HTR1A—Parkinson's disease	0.00106	0.00111	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HTR1A—Parkinson's disease	0.00106	0.00111	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GRM4—Parkinson's disease	0.00106	0.0011	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GRM4—Parkinson's disease	0.00105	0.0011	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—TAC1—Parkinson's disease	0.00105	0.00109	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—TAC1—Parkinson's disease	0.00104	0.00109	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DRD1—Parkinson's disease	0.00103	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DRD1—Parkinson's disease	0.00102	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00102	0.00107	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00102	0.00106	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PENK—Parkinson's disease	0.001	0.00105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MAG—Parkinson's disease	0.001	0.00105	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PENK—Parkinson's disease	0.000999	0.00104	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MAG—Parkinson's disease	0.000999	0.00104	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DRD3—Parkinson's disease	0.000996	0.00104	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DRD3—Parkinson's disease	0.000992	0.00104	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—HTR7—Parkinson's disease	0.000991	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—DRD2—Parkinson's disease	0.000991	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—HTR7—Parkinson's disease	0.000988	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—DRD2—Parkinson's disease	0.000988	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—PLA2G6—Parkinson's disease	0.000984	0.00103	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MAOB—Parkinson's disease	0.000974	0.00102	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00093	0.00097	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—ADRBK1—Parkinson's disease	0.000927	0.000967	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—PDYN—Parkinson's disease	0.000917	0.000956	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—PDYN—Parkinson's disease	0.000914	0.000953	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HTR7—Parkinson's disease	0.0009	0.000939	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—DRD2—Parkinson's disease	0.0009	0.000939	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HTR7—Parkinson's disease	0.000897	0.000936	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—DRD2—Parkinson's disease	0.000897	0.000936	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GFAP—Parkinson's disease	0.000862	0.000899	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GFAP—Parkinson's disease	0.000859	0.000896	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—GRM5—Parkinson's disease	0.000852	0.000889	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—GRM5—Parkinson's disease	0.00085	0.000886	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Circadian rythm related genes—IL6—Parkinson's disease	0.000798	0.000833	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—EDN1—Parkinson's disease	0.000794	0.000828	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—EDN1—Parkinson's disease	0.000791	0.000826	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000756	0.000789	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.000754	0.000786	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—FGF20—Parkinson's disease	0.000747	0.00078	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—FGF20—Parkinson's disease	0.000745	0.000777	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADORA2A—Parkinson's disease	0.000725	0.000756	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP2D6—Parkinson's disease	0.000724	0.000755	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADORA2A—Parkinson's disease	0.000722	0.000754	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—EDN1—Parkinson's disease	0.000721	0.000752	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—EDN1—Parkinson's disease	0.000719	0.00075	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CTGF—Parkinson's disease	0.000711	0.000741	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000694	0.000724	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—GPCR downstream signaling—HTR2A—Parkinson's disease	0.000692	0.000722	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INSR—Parkinson's disease	0.000669	0.000698	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INSR—Parkinson's disease	0.000667	0.000695	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYP2E1—Parkinson's disease	0.000662	0.000691	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—NQO1—Parkinson's disease	0.000655	0.000683	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—TH—Parkinson's disease	0.000645	0.000673	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—FGB—Parkinson's disease	0.000632	0.000659	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—HTR2A—Parkinson's disease	0.000631	0.000658	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—FGB—Parkinson's disease	0.00063	0.000657	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR1A—Parkinson's disease	0.000629	0.000656	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—HTR2A—Parkinson's disease	0.000629	0.000656	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR1A—Parkinson's disease	0.000627	0.000654	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—CYCS—Parkinson's disease	0.000619	0.000646	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—TAC1—Parkinson's disease	0.000619	0.000646	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—TAC1—Parkinson's disease	0.000617	0.000644	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DRD1—Parkinson's disease	0.000607	0.000634	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DRD1—Parkinson's disease	0.000605	0.000632	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DRD3—Parkinson's disease	0.000588	0.000614	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DRD3—Parkinson's disease	0.000586	0.000612	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—ADRBK1—Parkinson's disease	0.000549	0.000573	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—COMT—Parkinson's disease	0.000549	0.000572	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—ADRBK1—Parkinson's disease	0.000547	0.000571	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GSTP1—Parkinson's disease	0.000546	0.00057	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MAOA—Parkinson's disease	0.000545	0.000568	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—HMOX1—Parkinson's disease	0.000539	0.000562	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—DRD2—Parkinson's disease	0.000532	0.000555	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR7—Parkinson's disease	0.000532	0.000555	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—DRD2—Parkinson's disease	0.00053	0.000553	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR7—Parkinson's disease	0.00053	0.000553	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—ABCB1—Parkinson's disease	0.000517	0.000539	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GSTM1—Parkinson's disease	0.000502	0.000524	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—GPX1—Parkinson's disease	0.000481	0.000501	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IGF2—Parkinson's disease	0.000446	0.000465	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IGF2—Parkinson's disease	0.000444	0.000464	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—MTHFR—Parkinson's disease	0.000443	0.000463	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IGF1R—Parkinson's disease	0.000431	0.00045	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IGF1R—Parkinson's disease	0.00043	0.000448	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—EDN1—Parkinson's disease	0.000426	0.000444	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—EDN1—Parkinson's disease	0.000424	0.000443	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—APOE—Parkinson's disease	0.000413	0.000431	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—NGF—Parkinson's disease	0.000391	0.000408	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—NGF—Parkinson's disease	0.00039	0.000407	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—HTR2A—Parkinson's disease	0.000373	0.000389	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—HTR2A—Parkinson's disease	0.000371	0.000387	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Metabolism—INS—Parkinson's disease	0.000353	0.000368	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—APOE—Parkinson's disease	0.000346	0.000361	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—APOE—Parkinson's disease	0.000345	0.00036	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—INS—Parkinson's disease	0.000296	0.000309	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—INS—Parkinson's disease	0.000295	0.000308	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—CASP3—Parkinson's disease	0.00022	0.00023	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—CASP3—Parkinson's disease	0.00022	0.000229	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling by GPCR—IL6—Parkinson's disease	0.000219	0.000228	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling by GPCR—IL6—Parkinson's disease	0.000218	0.000228	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—MAPK8—Parkinson's disease	0.000202	0.000211	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—MAPK8—Parkinson's disease	0.000202	0.000211	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM1—Signaling Pathways—IL6—Parkinson's disease	0.000129	0.000135	CbGpPWpGaD
Diphemanil Methylsulfate—CHRM3—Signaling Pathways—IL6—Parkinson's disease	0.000129	0.000134	CbGpPWpGaD
